Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Operating Income
58,462.00
52,578.00
48,496.00
43,885.00
38,654.00
33,498.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
58,462.00
52,578.00
48,496.00
43,885.00
38,654.00
33,498.00
Expenditure (Ex Depriciation)
Stock Adjustments
343.00
150.00
292.00
-686.00
-107.00
-638.00
Raw Materials Consumed
11,200.00
10,597.00
10,370.00
11,349.00
10,459.00
9,328.00
Power & Fuel Cost
813.00
750.00
760.00
830.00
702.00
627.00
Employee Cost
11,418.00
9,973.00
9,429.00
8,296.00
7,300.00
6,862.00
Operating Expenses
2,564.00
2,261.00
2,186.00
1,936.00
1,880.00
1,723.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
7,748.00
6,576.00
5,780.00
5,226.00
4,096.00
3,103.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
1,799.00
1,537.00
1,437.00
1,031.00
807.00
843.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
41,970.00
37,492.00
35,509.00
32,238.00
28,410.00
25,030.00
Operating Profit (PBDIT) excl Other Income
16,491.00
15,086.00
12,987.00
11,646.00
10,243.00
8,467.00
Other Income
3,211.00
2,150.00
1,390.00
634.00
1,075.00
859.00
Operating Profit (PBDIT)
19,703.00
17,236.00
14,377.00
12,281.00
11,319.00
9,326.00
Interest
338.00
231.00
238.00
172.00
127.00
141.00
Profit before Depriciation and Tax
19,364.00
17,005.00
14,138.00
12,109.00
11,191.00
9,185.00
Depreciation
2,937.00
2,575.00
2,556.00
2,529.00
2,143.00
2,079.00
Profit Before Taxation & Exceptional Items
16,426.00
14,429.00
11,582.00
9,579.00
9,048.00
7,105.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
15,118.00
13,752.00
11,087.00
9,408.00
4,481.00
2,799.00
Provision for Tax
3,554.00
2,772.00
1,439.00
847.00
1,075.00
514.00
Profit After Tax
11,564.00
10,980.00
9,648.00
8,560.00
3,405.00
2,284.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
57,861.00
50,154.00
43,610.00
37,645.00
36,598.00
35,320.00
Profit Available for appropriations
69,341.00
61,083.00
53,186.00
46,119.00
39,870.00
38,223.00
Appropriations
69,341.00
61,083.00
53,186.00
46,119.00
39,870.00
38,223.00
Equity Dividend (%)
1,600.00%
1,600.00%
1,350.00%
1,150.00%
1,000.00%
750.00%
Earnings Per Share
47.80
45.60
39.90
35.30
13.60
12.10
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 11.19% vs 8.42% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 9.31% vs 16.16% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 46.49% vs -2.98% in Mar 2025
Profit After Tax
YoY Growth in year ended Mar 2026 is 5.32% vs 13.80% in Mar 2025
Compare Profit and Loss Results of Sun Pharma.Inds.
Figures in Cr
consolidated - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
58,462.00
9,360.00
49,102.00
524.59%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
58,462.00
9,360.00
49,102.00
524.59%
Expenditure (Ex Depriciation)
Stock Adjustments
343.00
-96.00
439.00
457.29%
Raw Materials Consumed
11,200.00
3,821.00
7,379.00
193.12%
Power & Fuel Cost
813.00
465.00
348.00
74.84%
Employee Cost
11,418.00
1,243.00
10,175.00
818.58%
Operating Expenses
2,564.00
387.00
2,177.00
562.53%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
7,748.00
136.00
7,612.00
5,597.06%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
1,799.00
157.00
1,642.00
1,045.86%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
41,970.00
6,391.00
35,579.00
556.70%
Operating Profit (PBDIT) excl Other Income
16,491.00
2,969.00
13,522.00
455.44%
Other Income
3,211.00
352.00
2,859.00
812.22%
Operating Profit (PBDIT)
19,703.00
3,321.00
16,382.00
493.29%
Interest
338.00
3.00
335.00
11,166.67%
Profit before Depriciation and Tax
19,364.00
3,318.00
16,046.00
483.60%
Depreciation
2,937.00
402.00
2,535.00
630.60%
Profit Before Taxation & Exceptional Items
16,426.00
2,916.00
13,510.00
463.31%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
15,118.00
2,916.00
12,202.00
418.45%
Provision for Tax
3,554.00
725.00
2,829.00
390.21%
Profit After Tax
11,564.00
2,191.00
9,373.00
427.80%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
57,861.00
11,786.00
46,075.00
390.93%
Profit Available for appropriations
69,341.00
13,977.00
55,364.00
396.11%
Appropriations
69,341.00
13,977.00
55,364.00
396.11%
Equity Dividend (%)
1600%
1500%
100.00
Earnings Per Share
47.8
82.53
-34.73
-42.08%
Profit And Loss - Net Sales
Net Sales 58,462.04 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 11.19% vs 8.42% in Mar 2025
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 16,491.22 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 9.31% vs 16.16% in Mar 2025
Profit And Loss - Interest
Interest 338.91 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 46.49% vs -2.98% in Mar 2025
Profit And Loss - Profit After Tax
Profit After Tax 11,564.52 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 5.32% vs 13.80% in Mar 2025






